Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will boost its ability to develop medicines against targets once consider
Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved
